findmyKOL

Matthew Bernabei, MD

Basic profile

Lancaster General Hospital

ORCIDNone on fileNPI
RegionLancaster, PA · NortheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Matthew Bernabei is a Cardiology physician affiliated with Lancaster General Hospital. OpenAlex indexes 22 publications with 1,383 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Distinct works indexed by OpenAlex.

1,383citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

217 Harrisburg Ave
The Heart Group Of Lghealth
Lancaster, PA 176032962

Telephone

717-544-8300

Registry record last updated 3 Feb 2015.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.9%
    Beta blocker35.4%
    Metoprolol Tartrate49%Metoprolol Succinate28%Sotalol12%Carvedilol12%
    Part D<11 patients
    Antiarrhythmic19.4%
    Amiodarone Hcl89%Flecainide Acetate12%
    Part D<11 patients

    + 4 more classes in this area

  • Blood & clotting

    21.1%
    Factor Xa inhibitor17.5%
    Eliquis100%
    Part D35 patients
    Vitamin K antagonist3.5%
    Warfarin Sodium100%
    Part D13 patients
  • Metabolism & gastrointestinal

    5%
    Proton pump inhibitor5%
    Pantoprazole Sodium100%
    Part D27 patients
Where care is delivered (Part B)26% facility · 74% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”